IANNETTA, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 8.136
AS - Asia 4.276
EU - Europa 2.821
SA - Sud America 667
Continente sconosciuto - Info sul continente non disponibili 608
AF - Africa 96
OC - Oceania 26
Totale 16.630
Nazione #
US - Stati Uniti d'America 7.858
SG - Singapore 1.996
IT - Italia 1.019
CN - Cina 635
BR - Brasile 546
HK - Hong Kong 498
RU - Federazione Russa 449
VN - Vietnam 355
IE - Irlanda 294
BD - Bangladesh 292
DE - Germania 203
FR - Francia 153
GB - Regno Unito 148
SE - Svezia 146
CA - Canada 141
JP - Giappone 127
NL - Olanda 87
FI - Finlandia 85
IN - India 84
ID - Indonesia 51
AT - Austria 49
MX - Messico 48
AR - Argentina 45
TR - Turchia 44
PL - Polonia 41
ES - Italia 40
IQ - Iraq 33
ZA - Sudafrica 28
KR - Corea 26
AU - Australia 25
PK - Pakistan 22
CO - Colombia 19
EC - Ecuador 19
JM - Giamaica 19
IL - Israele 16
CR - Costa Rica 15
IR - Iran 14
PH - Filippine 12
VE - Venezuela 12
UA - Ucraina 11
BE - Belgio 10
CL - Cile 10
CZ - Repubblica Ceca 10
EG - Egitto 10
GT - Guatemala 10
KE - Kenya 10
LT - Lituania 10
MA - Marocco 10
CH - Svizzera 9
PY - Paraguay 9
SA - Arabia Saudita 9
HN - Honduras 8
JO - Giordania 8
NG - Nigeria 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
DK - Danimarca 7
GR - Grecia 7
MY - Malesia 7
NI - Nicaragua 7
TT - Trinidad e Tobago 7
EE - Estonia 6
SC - Seychelles 6
SV - El Salvador 6
UZ - Uzbekistan 6
CW - ???statistics.table.value.countryCode.CW??? 5
KG - Kirghizistan 5
PE - Perù 5
RO - Romania 5
AZ - Azerbaigian 4
BB - Barbados 4
BH - Bahrain 4
DO - Repubblica Dominicana 4
EU - Europa 4
GH - Ghana 4
HU - Ungheria 4
NP - Nepal 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
DZ - Algeria 3
HR - Croazia 3
LV - Lettonia 3
MK - Macedonia 3
PR - Porto Rico 3
SI - Slovenia 3
TW - Taiwan 3
AL - Albania 2
AM - Armenia 2
BG - Bulgaria 2
ET - Etiopia 2
LC - Santa Lucia 2
OM - Oman 2
PA - Panama 2
PT - Portogallo 2
RS - Serbia 2
SN - Senegal 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
Totale 16.017
Città #
Singapore 1.041
Ashburn 868
San Jose 802
Hong Kong 489
Fairfield 359
Council Bluffs 327
Rome 301
Wilmington 300
Beijing 266
Chandler 261
Houston 223
Dublin 220
New York 204
Los Angeles 190
Santa Clara 175
Medford 150
The Dalles 139
Woodbridge 136
Tokyo 126
Ho Chi Minh City 124
Seattle 123
Cambridge 118
Buffalo 96
Ann Arbor 80
North Bergen 80
Dallas 76
Hanoi 74
Lawrence 69
Milan 66
Lauterbourg 65
Moscow 62
Denver 59
Chicago 58
Helsinki 55
Nuremberg 55
San Diego 51
Munich 47
São Paulo 47
Frankfurt am Main 42
Toronto 41
Orem 37
Atlanta 35
Naples 34
London 30
Jakarta 29
Brooklyn 28
Lappeenranta 26
Seoul 25
Montreal 24
Phoenix 24
Rio de Janeiro 22
Warsaw 22
Chennai 21
Curitiba 21
Menlo Park 21
Da Nang 20
San Francisco 19
Mexico City 18
Salt Lake City 18
Amsterdam 17
Boardman 17
Engelhard 17
Stockholm 17
Philadelphia 16
Tampa 15
Vienna 15
Ankara 14
Colorado Springs 14
Haiphong 14
Paris 14
Bologna 13
Johannesburg 13
Kingston 13
Manchester 13
Falls Church 12
Istanbul 12
Las Vegas 12
Miami 12
Palo Alto 12
San José 12
Adelaide 11
Kilburn 11
Minneapolis 11
Mumbai 11
Queens 11
Washington 11
Belo Horizonte 10
Boston 10
Brussels 10
Elk Grove Village 10
Florence 10
Guangzhou 10
Newark 10
North Charleston 10
Redondo Beach 10
St Louis 10
Charlotte 9
Quito 9
Shanghai 9
Sydney 9
Totale 9.035
Nome #
Low testosterone levels and high estradiol to testosterone ratio are associated with hyperinflammatory state and mortality in hospitalized men with COVID-19 422
Reactivation of Hepatitis B Virus With Immune-Escape Mutations After Ocrelizumab Treatment for Multiple Sclerosis 338
Depressive and anxiety symptoms in patients with SARS-CoV2 infection 224
P-375. Long-Term Suppressive Antimicrobial Therapy in Prosthetic Vascular Graft Infection: a Five-Year Retrospective Evaluation 219
Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection 197
Mild clinical manifestations of SARS-CoV-2 related pneumonia in two patients with multiple sclerosis under treatment with ocrelizumab 194
Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients 193
Cryptic HBV replicative activity is frequently revealed in anti-HBC-positive/hbsag-negative patients with HIV infection by highly sensitive molecular assays, and can be predicted by integrating classical and novel serological HBV markers 193
Low Vitamin D Status at Admission as a Risk Factor for Poor Survival in Hospitalized Patients With COVID-19: An Italian Retrospective Study 189
Sarilumab plus standard of care vs standard of care for the treatment of severe COVID-19: a phase 3, randomized, open-labeled, multi-center study (ESCAPE study) 184
Expression profile of HERVs and inflammatory mediators detected in nasal mucosa as a predictive biomarker of COVID-19 severity 177
Chikungunya Outbreak in the Republic of the Congo, 2019—Epidemiological, Virological and Entomological Findings of a South-North Multidisciplinary Taskforce Investigation 172
Frequency of atypical mutations in the spike glycoprotein in SARS-CoV-2 circulating from July 2020 to July 2022 in central Italy: a refined analysis by Next Generation Sequencing 171
Long-term SARS-CoV-2 infection associated with viral dissemination in different body fluids Including bile in two patients with acute cholecystitis 169
HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015-21 165
B- and T-Cell Responses After SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications 158
T-cell responses to SARS-CoV-2 in Multiple Sclerosis patients treated with ocrelizumab healed from COVID-19 with absent or low anti-Spike antibody titers 157
Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in {SARS}-{CoV}-2 infected patients: a single center study 154
Longitudinal Evaluation of the QuantiFERON-TB Gold Plus Assay in Hospitalized COVID-19 Patients with a First Indeterminate Result: Resolution of Inflammation and Restoration of T-Lymphocyte Counts and Interferon-Gamma Production 147
Thymosin Alpha 1 Mitigates Cytokine Storm in Blood Cells From Coronavirus Disease 2019 Patients 145
In patients with severe COVID-19, the profound decrease in the peripheral Bblood T-cell subsets is correlated with an increase of QuantiFERON-TB Gold Plus indeterminate rates and reflecting a reduced interferon-gamma production 142
Persistence of circulating CD169+monocytes and HLA-DR downregulation underline the immune response impairment in PASC individuals: the potential contribution of different COVID-19 pandemic waves 139
High CD169 monocyte/lymphocyte ratio reflects immunophenotype disruption and oxygen need in COVID-19 patients 138
Dynamic changes of MMP-9 plasma levels correlate with JCV reactivation and immune activation in natalizumab-treated multiple sclerosis patients 136
Human Arboviral Infections in Italy: Past, Current, and Future Challenges 133
Thymosin alpha 1 restores the immune homeostasis in lymphocytes during Post-Acute sequelae of SARS-CoV-2 infection 132
Early and Polyantigenic CD4 T Cell Responses Correlate with Mild Disease in Acute COVID-19 Donors 131
Bactericidal and synergistic activity of double-carbapenem regimen for infections caused by carbapenemase-producing Klebsiella pneumoniae 128
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection 128
Brain abscess caused by Actinomyces turicensis in a non-immunocompromised adult patient: a case report and systematic review of the literature 127
Prevalence of hepatitis D virus infection in Central Italy has remained stable across the last 2 decades with dominance of subgenotypes 1 and characterized by elevated viral replication 126
Resistance to Ceftazidime/Avibactam in Klebsiella pneumoniae KPC-Producing Isolates: A Real-Life Observational Study 124
Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon 124
Persistent detection of dengue virus RNA in vaginal secretion of a woman returning from Sri Lanka to Italy, April 2017 123
Circulation of sars-cov-2 variants in central Italy: spike variability characterization by deep-sequencing. 122
Human polyomavirus JC replication and non-coding control region analysis in multiple sclerosis patients under natalizumab treatment 122
Archetype and rearranged non-coding control regions in urothelial bladder carcinoma of immunocompetent individuals 121
Conventional Dendritic Cells and Slan+ Monocytes During HIV-2 Infection 120
The Impact of Viral and Bacterial Co-Infections and Home Antibiotic Treatment in SARS-CoV-2 Hospitalized Patients at the Policlinico Tor Vergata Hospital, Rome, Italy 118
Validation of the T-Lymphocyte Subset Index (TLSI) as a Score to Predict Mortality in Unvaccinated Hospitalized COVID-19 Patients 118
Myeloid and lymphoid activation markers in AIDS and non-AIDS presenters 118
Utility of accessible SARS-CoV-2 specific immunoassays in vaccinated adults with a history of advanced HIV infection 118
The Omicron Variant Is Associated with a Reduced Risk of the Post COVID-19 Condition and Its Main Phenotypes Compared to the Wild-Type Virus: Results from the EuCARE-POSTCOVID-19 Study 117
Natalizumab affects T-Cell phenotype in multiple sclerosis: Implications for JCV reactivation 117
Blood myeloid dendritic cells and slanDC in antiretroviral therapy-Suppressed HIV-infected patients 116
Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection 116
Role of sonication in the microbiological diagnosis of implant-associated infections: beyond the orthopedic prosthesis 116
High CD169 Monocyte/Lymphocyte Ratio Reflects the Immunophenotyping Disruption and Predicts Oxygen Need in COVID-19 Patients 116
T Lymphocyte Subset Counts and Interferon-Gamma Production in Adults and Children with COVID-19: A Narrative Review 114
Immune activation, immunosenescence, and osteoprotegerin as markers of endothelial dysfunction in subclinical hiv-associated atherosclerosis 114
Admission eGFR predicts in-hospital mortality independently of admission glycemia and C-peptide in patients with type 2 diabetes mellitus and COVID-19 113
Low testosterone levels and high estradiol to testosterone ratio are associated with hyperinflammatory state and mortality in hospitalized men with COVID-19 (vol 25, pg 5889, 2021) 113
Remdesivir Influence on SARS-CoV-2 RNA Viral Load Kinetics in Nasopharyngeal Swab Specimens of COVID-19 Hospitalized Patients: A Real-Life Experience 113
Histoplasmosis in patients living with HIV in Europe: review of literature 113
HIV DNA viral reservoirs in blood and gut-associated lymphoid tissues (GALT): Implications of switch from triple antiretroviral therapy (ART) to 2-drug dolutegravir/lamivudine regimens 112
Azithromycin Shows Anti-Zika Virus Activity in Human Glial Cells 112
Role of HBcAb Positivity in Increase of HIV-RNA Detectability after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Months 48 Results of a Multicenter Italian Cohort 111
HIV-associated progressive multifocal leukoencephalopathy: Longitudinal study of JC virus non-coding control region rearrangements and host immunity 111
ZIKV infection induces an inflammatory response but fails to activate types I, II, and III IFN response in human PBMC 110
Altered antigen-presenting cells during HIV-1 infection 109
An in-depth characterization of VOCs circulation by using NGS analysis of the Spike protein. 108
In vivo and in vitro effects of antituberculosis treatment on mycobacterial interferon-γ T cell response 108
Imported severe malaria and risk factors for intensive care: A single-centre retrospective analysis 107
JC Virus-DNA Detection Is Associated with CD8 Effector Accumulation in Peripheral Blood of Patients with Multiple Sclerosis under Natalizumab Treatment, Independently from JC Virus Serostatus 106
Sustained Remission in Relapsed/Refractory Diffuse Large B Cell Lymphoma Following Glofitamab Discontinuation Due to JC Virus Reactivation: Balancing Efficacy and Infectious Risk 105
HUMAN ENDOGENOUS RETROVIRUSES EXPRESSION CORRELATES WITH HIV RESERVOIR, LYMPHOCYTES ACTIVATION AND LOW CD4 COUNT IN VIROLOGICALLY SUPPRESSED PATIENTS 105
Cell-associated {HIV} cross-presentation by plasmacytoid dendritic cells is potentiated by noncognate {CD}8$mathplus$ T cell preactivation 105
Infectious risk in multiple sclerosis patients treated with disease-modifying therapies: a three-year observational cohort study 104
Unexpected human cases of cutaneous anthrax in Latium region, Italy, August 2017: integrated human-animal investigation of epidemiological, clinical, microbiological and ecological factors 103
Severe Plasmodium ovale malaria complicated by acute respiratory distress syndrome in a young Caucasian man 102
Viral Hemorrhagic Fevers Other than Ebola and Lassa 102
Latent Tuberculosis Infection in Haematopoietic Stem Cell Transplant Recipients: A Retrospective Italian Cohort Study in Tor Vergata University Hospital, Rome 101
An In-Depth Characterization of SARS-CoV-2 Omicron Lineages and Clinical Presentation in Adult Population Distinguished by Immune Status 101
HDV replicative activity parallels the production of the three HBsAg forms (Large, Middle and Small HBsAg) and its pathogenetic impact is exacerbated by concomitant HBV replication 100
Evaluation of S-RBD and high specificity ACE-2-binding antibodies on SARS-CoV-2 patients after six months from infection 100
Humoral Response after Two Doses of BNT162b2 mRNA Vaccine Has a Role in Predicting Response after Three Doses That Is Related to Plasma HIV Viremia and Nadir CD4+ Cell Count in HIV-Positive Patients 99
Hiv-2 infection in a migrant from gambia: The history of the disease combined with phylogenetic analysis revealed the real source of infection 99
Higher levels of three HBsAg forms (Large, Middle and Small HBsAg) are associated with HDV replication and with the degree of disease and liver damage. 99
Case report: Delayed diagnosis of congenital malaria by plasmodium vivax in a newborn of an Eritrean woman with varicella infection 98
Diagnostic value of JC polyomavirus viruria, viremia, serostatus and microRNA expression in multiple sclerosis patients undergoing immunosuppressive treatment 97
Epidemiological and Clinical Features of SARS-CoV-2 Variants Circulating between April–December 2021 in Italy 96
Drug-Induced Progressive Multifocal Leukoencephalopathy (PML): A Systematic Review and Meta-Analysis 96
Severe bloodstream infection due to KPC-producer e coli in a renal transplant recipient treated with the double-carbapenem regimen and analysis of in vitro synergy testing a case report 96
Impact of IFN-Free and IFN-Based Treatment on Blood Myeloid Dendritic Cell, Monocyte, Slan-DC, and Activated T Lymphocyte Dynamics during HCV Infection. 96
Chronic HDV coinfection (CHD) is characterized by a different HBsAg isoforms composition respect to HBV mono-infection with higher middle- and large-HBs levels paralleling the replicative and cytolytic activity of HDV. 95
HBcAb Positivity Is a Risk Factor for an Increased Detectability of HIV RNA After Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Analysis of a Multicenter Italian Cohort 95
The evolving landscape of COVID-19: Factors associated with in-hospital COVID-19 related mortality during the 2023-2024 phase of JN.1 subvariant dominance 94
In vivo release of alpha-defensins in plasma, neutrophils and CD8 T-lymphocytes of patients with HIV infection 94
Real-life Data on Cefiderocol Efficacy and Safety to Treat Multidrug-Resistant Acinetobacter baumannii Infections 93
First Evidence of Pathogenic HERV-W Envelope Expression in T Lymphocytes in Association with the Respiratory Outcome of COVID-19 Patients 93
Synergistic activity and effectiveness of a double-carbapenem regimen in pandrug-resistant Klebsiella pneumoniae bloodstream infections 92
Early Atherosclerosis in HIV Infected Subjects on Suppressive Antiretroviral Treatment: Role of Osteoprotegerin 91
Pacemaker lead endocarditis due to multidrug-resistant Corynebacterium striatum detected with sonication of the device 91
Hepatitis B-related hepatic flare during immune reconstitution syndrome after antiretroviral treatment initiation in an HBV surface antigen-positive patient with HIV: viroimmunological and histological characterization 90
A peculiar HBsAg isoforms composition characterizes chronic HDV coinfection respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity. 90
NMR-based metabolomic approach to study urine samples of chronic inflammatory rheumatic disease patients 90
HIV-associated progressive multifocal leukoencephalopathy: Current perspectives 90
Prolonged detection of dengue virus RNA in the semen of a man returning from Thailand to Italy, january 2018 90
JCPyV NCCR analysis in PML patients with different risk factors: exploring common rearrangements as essential changes for neuropathogenesis 90
Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia 90
Totale 12.700
Categoria #
all - tutte 81.297
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.297


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022709 0 0 0 128 8 77 58 70 63 58 33 214
2022/2023845 84 44 51 62 75 214 92 64 65 12 42 40
2023/2024643 64 22 58 88 43 102 29 44 14 71 23 85
2024/20253.253 72 571 396 193 55 183 334 167 308 431 251 292
2025/20266.540 650 257 607 526 520 261 792 723 806 516 481 401
2026/20272.988 506 399 1.040 1.043 0 0 0 0 0 0 0 0
Totale 16.630